Related Experiment Videos
Raised serum lipid concentrations during diuretic treatment of hypertension: a study of predictive indexes
Insights
Diuretic hypertension treatments impact blood lipids differently. Hydrochlorothiazide increased cholesterol, while spironolactone raised triglycerides, potentially affecting coronary risk in certain patients.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Medicine
Background:
- Hypertension management often involves diuretics.
- The effects of common diuretics on serum lipid profiles require further elucidation.
Purpose of the Study:
- To investigate the impact of hydrochlorothiazide and spironolactone on serum lipid concentrations in hypertensive patients.
- To identify patient subgroups susceptible to lipid level alterations during diuretic therapy.
Main Methods:
- Serum cholesterol and triglyceride levels were measured pre- and during treatment.
- Thirty-six patients received hydrochlorothiazide; 29 received spironolactone.
- Subgroup analysis was performed to identify factors associated with lipid changes.
Main Results:
- Hydrochlorothiazide increased serum cholesterol (P < 0.005) but not triglycerides.
- Spironolactone increased serum triglycerides (P < 0.05) but not cholesterol.
- Younger patients with lower baseline cholesterol and blood pressure showed greater cholesterol increases with hydrochlorothiazide, with no improvement in coronary risk status.
Conclusions:
- Diuretic choice influences lipid profiles in hypertension treatment.
- Specific patient characteristics predict lipid responses to diuretics.
- Current first-line diuretic use in mild hypertension may not effectively reduce myocardial infarction incidence.
Abstract:
1. The serum concentrations of cholesterol and triglycerides were measured before and during the treatment of hypertension. Thirty-six patients were treated with hydrochlorothiazide and 29 with spironolactone. 2. Serum cholesterol increased from 214 to 227 mg/100 ml (P less than 0.005) and triglyceride did not change during treatment with hydrochlorothiazide. Serum triglyceride increased from 112 to 133 mg/100 ml (P less than 0.05) and cholesterol did not change during treatment with spironolactone. 3. Serum lipid responses to diuretics varied among patients. To identify patients susceptible to larger increases, subgroup analysis was carried out. Patients who were younger and had lower pretreatment serum cholesterol and systolic blood pressure had larger increments in cholesterol during treatment. In these subgroups coronary risk status did not improve during therapy. 4. The incidence of myocardial infarction may not be reduced so long as diuretics serve as first-line drugs in the treatment of mild hypertension.